Multicenter Study for the Safety and Efiicacy of Human Antibody Adalimumab in subjects with Active Ankylosing Spondylitis

Atukorala I
Publication year: 2017

Phase III, Multicenter Study for the Safety and Efiicacy of Human Antibody Adalimumab in subjects with Active Ankylosing Spondylitis

Leave a Reply

Your email address will not be published. Required fields are marked *